Skorpios Trust
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 5, 2024), Skorpios Trust reported 2 stock positions worth $146.7 million. Its top holding was Stoke Therapeutics (STOK) at 99.9% of the portfolio, followed by SS SPDR S&P Biotech ETF (XBI, 0.1%). Compared with Q1 2024, it reduced 1. The biggest sale was Stoke Therapeutics (STOK, shares −25%).
- Most Recent 13F
- Q3 2025
- Location
- LIMASSOL, G4
- CIK
- 0001869333
- Portfolio Value
- $146.7M (Q2 2024)
- SEC Filing
- 0001123292-24-000211 ↗ filed Aug 5, 2024
Holdings Value
Holdings 2 stocks · $146.7M
Portfolio Sells Q1 2024 → Q2 2024
| STOK Stoke Therapeutics Inc. | Reduce -24.9% | 99.89% | −0.02 |
Portfolio Buys Q1 2024 → Q2 2024
| None this quarter. | |||